Combined culture and metagenomic analyses reveal significant shifts in the composition of the cutaneous microbiome in psoriasis

AcnePsoriasis

The role of the microbiome in psoriasis: moving from disease description to treatment prediction?

Br J Dermatol.

Langan EA, Griffiths CEM, Solbach W, Knobloch JK, Zillikens D, Thaçi D

doi: 10.1111/bjd.16081.

COMMENTED

Psoriasis

Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practice

J Eur Acad Dermatol Venereol.

Maul JT, Navarini AA, Sommer R, Anzengruber F, Sorbe C, Mrowietz U, Drach M, Blome C, Boehncke WH, Thaci D, Reich K, von Kiedrowski R, Körber A, Yawalkar N, Mainetti C, Laffitte E, Streit M, Rustenbach S, Conrad C, Borradori L, Gilliet M, Cozzio A, Itin P, Häusermann P, French LE, Radtke MA, Augustin M

doi: 10.1111/jdv.15324.

PsoriasisPsoriatic Arthritis

Comparative microscopic analysis of nail clippings from patients with cutaneous psoriasis and psoriatic arthritis

An Bras Dermatol.

Fonseca GP, Werner B, Seidel G, Staub HL

doi: 10.1590/

Atopic Dermatitis

Atopic dermatitis shows significant cutaneous comorbidity: results from large-scale investigations in the working population

J Eur Acad Dermatol Venereol.

Zander N, Augustin M, Reinert R, Schäfer I

doi: 10.1111/jdv.15792.

Psoriatic Arthritis

Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis

Rheumatology (Oxford).

Coates LC, Merola JF, Mease PJ, Ogdie A, Gladman DD, Strand V, van Mens LJJ, Liu L, Yen PK, Collier DH, Kricorian G, Chung JB, Helliwell PS

doi: 10.1093/rheumatology/

Psoriasis

Quality of life and patient-perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed-dose combination Cal/BD foam: a post-hoc analysis of PSO-LONG

J Eur Acad Dermatol Venereol

Jalili A, Calzavara-Pinton P, Kircik L, Lons-Danic D, Pink A, Tyring S, de la Cueva P, Gooderham M, Segaert S, Nyholm N, Thoning H, Petersen B, Thaçi D

doi: 10.1111/jdv.17673

T Cells

A skewed pool of resident T cells triggers psoriasis-associated tissue responses in never-lesional psoriasis skin

J Allergy Clin Immunol.

Gallais Sérézal I, Hoffer E, Ignatov B, Martini E, Zitti B, Ehrström M, Eidsmo L

doi: 10.1016/j.jaci.

Psoriasis

Long-Term Safety and Efficacy of a Fixed Combination Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion in Moderate-to-Severe Plaque Psoriasis: Phase 3 Open-Label Study

J Eur Acad Dermatol Venereol

Lebwohl MG, Stein Gold L, Papp K, Han G, Pariser DM, Lin T, Harris S, Jacobson A

doi: 10.1111/jdv.17113

PsoriasisPsoriatic Arthritis

Broad proteomic screen reveals shared serum proteomic signature in patients with psoriatic arthritis and psoriasis without arthritis

Rheumatology (Oxford).

Leijten E, Tao W, Pouw J, van Kempen T, Olde Nordkamp M, Balak D, Tekstra J, Muñoz-Elías E, DePrimo S, Drylewicz J, Pandit A, Boes M, Radstake T

doi: 10.1093/rheumatology/keaa405.

Related content

The role of the microbiome in psoriasis: moving from disease description to treatment prediction?

Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practice

Comparative microscopic analysis of nail clippings from patients with cutaneous psoriasis and psoriatic arthritis

Atopic dermatitis shows significant cutaneous comorbidity: results from large-scale investigations in the working population

Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis

Quality of life and patient-perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed-dose combination Cal/BD foam: a post-hoc analysis of PSO-LONG

A skewed pool of resident T cells triggers psoriasis-associated tissue responses in never-lesional psoriasis skin

Long-Term Safety and Efficacy of a Fixed Combination Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion in Moderate-to-Severe Plaque Psoriasis: Phase 3 Open-Label Study

Broad proteomic screen reveals shared serum proteomic signature in patients with psoriatic arthritis and psoriasis without arthritis